Kraig Biocraft Laboratories Inc. is a biotech company working to develop and commercialize high performance polymers. The company intends to break into the $92 billion market for high performance fibers by using spider silk genes.

The company intends to insert these genes into silkworms to make them produce fibers with the characteristics of spider silk, which is one of the strongest natural fibers known. In an effort to reach these goals, Kraig Biocraft has licensed the spider gene sequences patented by the University of Wyoming and the genetic developed technology by the University of Notre Dame.

Several weeks ago, Kraig Biocraft announced that during the months of May, June and July the scientific team succeeded in its previously announced attempt to ramp up the number of genetic insertions performed. The team’s initial goal was to double the number of DNA construct insertions performed in

Kraig Biocraft Laboratories Inc. is a biotech company working to develop and commercialize high performance polymers. The company intends to break into the $92 billion market for high performance fibers by using spider silk genes.

The company intends to insert these genes into silkworms to make them produce fibers with the characteristics of spider silk, which is one of the strongest natural fibers known. In an effort to reach these goals, Kraig Biocraft has licensed the spider gene sequences patented by the University of Wyoming and the genetic developed technology by the University of Notre Dame.

Several weeks ago, Kraig Biocraft announced that during the months of May, June and July the scientific team succeeded in its previously announced attempt to ramp up the number of genetic insertions performed. The team’s initial goal was to double the number of DNA construct insertions performed in

Kraig Biocraft Laboratories, Inc., a biotechnology company focused on the development of commercially significant polymers and high performance fibers, invests in genetic research and targeted product development to create innovative near-term solutions to meet the practical problems of our world. The company is currently working in cooperation with university scientists and laboratories to create new polymers with potentially broad applications for consumers and industry in the $92 billion marketplace for high-performance polymers.

Kraig Biocraft Laboratories develops collaborative relationships with leading universities and funds university scientists and laboratories to create technologies with significant commercial applications through the Kraig Research Initiative. As a part of this program, the company has licensed university intellectual property in the fields of genetics and genetic engineering.

The company sponsors and collaborates on research within various universities’ genetic engineering laboratories. In 2007, Kraig Biocraft Laboratories signed an intellectual property and collaborative research

Kraig Biocraft Laboratories, Inc., the Michigan-based company using genetic engineering to allow silkworms to produce spider silk, is making use of some of the most advanced insect-related genetic engineering techniques known. Scientists have already produced the first transgenic silkworms, and other scientists have discovered the sequence of genes used by spiders to produce silk. The brilliance of Kraig’s approach is the bringing together of researchers from both of these fields in a collaborative effort to produce commercially viable quantities of spider silk.

Kraig Biocraft has acquired the exclusive rights in this field to the genetic sequences patented by the University of Wyoming, and the genetic engineering technology developed by the University of Notre Dame. The company is now working in conjunction with the leading genetic scientists at these universities to produce a transgenic variety of silkworm capable of producing the elusive spider silk.

Kraig Biocraft Laboratories, Inc. is focused on the development of high performance technical fibers and polymers using spiders and silkworms. While the production of a “super fiber” is the company’s primary focus at this time, it is also considering the production of other unique proteins using transgenic silkworms. It is thought there is a large viable market for such proteins in the pharmaceutical and biotechnology industries.

Kraig Biocraft is involved in research related to utilizing spider genes for insertion into silkworms to create a transgenic variety of silkworms. These silkworms will be capable of spinning a new “super fiber” that is similar to natural spider silk, which is one of the strongest and most resilient fibers known. Natural spider silk is five times as strong as steel of the same diameter.

Kraig Biocraft has acquired the exclusive US rights, in their field of

Kraig Biocraft Laboratories Inc. is a cutting edge biotechnology company that is focused on the development of high performance fibers and polymers by creating transgenic silkworms inserted with spider genes. The goal is that these transgenic silkworms will spin a new “super fiber” similar to natural spider silk.

Spider silk is one of the strongest and most resilient fibers known. It has several properties that are unmatched by synthetic fibers. One property is spider silk’s ability to absorb energy and then dissipate the energy evenly. Another property is spider silk’s extreme resistance to breaking under strain. In this respect, spider silk outperforms all known fibers – natural and man-made. It is these properties that make spider silk especially attractive in applications for use in products such as bulletproof vests, artificial limbs, suspension cables and parachute cords.

Kraig Biocraft has acquired the exclusive rights to the

Kraig Biocraft Laboratories, Inc., the biotech company known for its pioneering work in genetic engineering for the production of spider silk and other polymers, is constantly breaking new ground in the field of genetics. As such, it is not surprising that they have assembled a remarkable team of scientific advisors to play a major role in everything they do.

• Malcolm J. Fraser, Jr., Ph.D, specializes in molecular genetics, and currently heads the Fraser Laboratory at the University of Notre Dame. During his post-doctoral work at Texas A&M, Dr. Fraser was part of the team which developed the genetic expression system for producing organic molecules, including pharmaceuticals, on an industrial scale. He is the co-inventor of the “piggyBac” gene splicing technology, and the named inventor for various patents involving its improvement.

He was recently selected as a fellow of the American Association for the Advancement

Kraig Biocraft Laboratories Inc. develops protein-based fiber using recombinant DNA technology. The company focuses on spider silk because of its exceptional strength and durability. Some spiders produce up to seven different types of silk, depending on its use, for catching prey, spinning a web, or traveling.

Since spiders are cannibals and hard to keep in colonies, the company maintains its focus on reproducing the fibers using transgenic silkworms. The idea is to create a transgenic variety of silkworms capable of spinning a new “super fiber” that is similar or an exact copy of natural spider silk, which is can be used in military and police departments, industrial and consumer applications, as well as for the aero-space industry.

In May of this year, Kraig Biocraft announced that it has successfully created eight DNA constructs, with the help of a team of scientists. Having teamed up

Kraig Biocraft Laboratories Inc. is a company focused on the development of high performance technical fibers and polymers utilizing spider genes for insertion into silkworms. The idea is to create a transgenic variety of silkworms capable of spinning a new “super fiber” that is similar or an exact copy of natural spider silk, which is one of the strongest and most resilient fibers known.

Kraig Biocraft has acquired the exclusive rights, in their field of use, to the genetic sequences patented by the University of Wyoming and the genetic engineering technology developed by the University of Notre Dame. The company is also working in conjunction with leading genetic engineers at these universities toward the goal of producing a transgenic variety of silkworms.

While the production of a “super fiber” is the primary focus of Kraig Biocraft at this time, the company is also considering the

Emerging biotech company, Kraig Biocraft Laboratories, Inc. was founded by the inventor of the company’s technology, current chief executive officer, Kim Thompson. The company is a fully reporting organization and trades on the over-the-counter market under the stock symbol KBLB. As of last report, there are about 501 million common shares outstanding, with approximately 64% held by the chief executive officer.

Kraig Biocraft Laboratories’ CEO serves as the overall coordinator for the company relative to business operations and ongoing research and development. Several prominent genetic scientists have significantly developed the companies’ technologies. Additionally, the laboratory staffs of these professors are also making significant contributions to the company’s efforts.

Kraig Biocraft Laboratories, Inc. has a developed intellectual portfolio relating to the harvesting of silk from genetically modified silkworms. The company brings together preeminent researchers in a collaborative effort to produce commercially significant quantities of